Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
8 min read
ADAMDEC1 Target Evaluation Report 2026: Biology, Validation, Competition, IP, and R&D Strategy
24 July 2026
A visual target evaluation report for ADAMDEC1, generated in a PatSnap Life Sciences MCP-style workflow covering biology, validation evidence, clinical competition, IP signals, and R&D strategy.
8 min read
ADAM33 Target Evaluation Report 2026: Biology, Validation, Competition, IP, and R&D Strategy
24 July 2026
A visual target evaluation report for ADAM33, generated in a PatSnap Life Sciences MCP-style workflow covering biology, validation evidence, clinical competition, IP signals, and R&D strategy.
8 min read
ADAM32 Target Evaluation Report 2026: Biology, Validation, Competition, IP, and R&D Strategy
24 July 2026
A visual target evaluation report for ADAM32, generated in a PatSnap Life Sciences MCP-style workflow covering biology, validation evidence, clinical competition, IP signals, and R&D strategy.
8 min read
ADAM30 Target Evaluation Report 2026: Biology, Validation, Competition, IP, and R&D Strategy
24 July 2026
A visual target evaluation report for ADAM30, generated in a PatSnap Life Sciences MCP-style workflow covering biology, validation evidence, clinical competition, IP signals, and R&D strategy.
8 min read
ADAM29 Target Evaluation Report 2026: Biology, Validation, Competition, IP, and R&D Strategy
24 July 2026
A visual target evaluation report for ADAM29, generated in a PatSnap Life Sciences MCP-style workflow covering biology, validation evidence, clinical competition, IP signals, and R&D strategy.
8 min read
ADAM28 Target Evaluation Report 2026: Biology, Validation, Competition, IP, and R&D Strategy
24 July 2026
A visual target evaluation report for ADAM28, generated in a PatSnap Life Sciences MCP-style workflow covering biology, validation evidence, clinical competition, IP signals, and R&D strategy.
8 min read
ADAM23 Target Evaluation Report 2026: Biology, Validation, Competition, IP, and R&D Strategy
24 July 2026
A visual target evaluation report for ADAM23, generated in a PatSnap Life Sciences MCP-style workflow covering biology, validation evidence, clinical competition, IP signals, and R&D strategy.
8 min read
ADAM22 Target Evaluation Report 2026: Biology, Validation, Competition, IP, and R&D Strategy
24 July 2026
A visual target evaluation report for ADAM22, generated in a PatSnap Life Sciences MCP-style workflow covering biology, validation evidence, clinical competition, IP signals, and R&D strategy.
8 min read
ADAM21 Target Evaluation Report 2026: Biology, Validation, Competition, IP, and R&D Strategy
24 July 2026
A visual target evaluation report for ADAM21, generated in a PatSnap Life Sciences MCP-style workflow covering biology, validation evidence, clinical competition, IP signals, and R&D strategy.
8 min read
ADAM20 Target Evaluation Report 2026: Biology, Validation, Competition, IP, and R&D Strategy
24 July 2026
A visual target evaluation report for ADAM20, generated in a PatSnap Life Sciences MCP-style workflow covering biology, validation evidence, clinical competition, IP signals, and R&D strategy.
8 min read
ADAM19 Target Evaluation Report 2026: Biology, Validation, Competition, IP, and R&D Strategy
24 July 2026
A visual target evaluation report for ADAM19, generated in a PatSnap Life Sciences MCP-style workflow covering biology, validation evidence, clinical competition, IP signals, and R&D strategy.
8 min read
ADAM18 Target Evaluation Report 2026: Biology, Validation, Competition, IP, and R&D Strategy
24 July 2026
A visual target evaluation report for ADAM18, generated in a PatSnap Life Sciences MCP-style workflow covering biology, validation evidence, clinical competition, IP signals, and R&D strategy.